The Center has consolidated research administration into one unit, to align more appropriately with the reorganized CCSG Program structure. It provides centralized corporate sen/ices, maintains single Center wide operating committees, and has centrally managed research facilities/services to promote efficiency and effectiveness. The research administrative team at Fox Chase Cancer Center (FCCC) primarily consists of the Vice President for Research Administration, an Assistant Vice President and a Shared Facility Administrator. These individuals are experienced in all aspects of research administration and participate in national research administrative groups, such as the Alliance of Dedicated Cancer Centers, the National Council of University Administrators and the Cancer Centers Administrators Forum. In addition to the time spent in research administration, the three key individuals have various Center-wide administrative responsibilities. Collectively, these three individuals provide the administrative support to all Cancer Center Programs and centralized scientific shared Facilities. They work closely with the Center President and Senior Vice Presidents on important Center initiatives (see Senior Leadership Description section) and they serve as administrative representatives on Center-wide committees. Each is supported by a staff that works in tandem to provide budgetary, grants management, space planning, and post-award support to investigators. A single administrator has responsibility for managing the CCSG. This individual oversees all financial transactions of CCSG Facilities, coordinates the annual progress report, manages the CCSG budget and assures compliance with CCSG regulations. Certain research grant functions have been centralized to achieve efficiency and effectiveness for all Center investigators. These centralized departments routinely interact with Research Administration. The centralized management provides for checks and balances in meeting NIH and other agency grant regulations. All pre-award activities (grant budgets, compliance with funding agency regulations and completion of most administrative application documents) are coordinated through our Office of Sponsored Research. All post-award activities (monitoring effort reports, reviewing grant charges, overseeing subcontracting activities, and filing final financial reports) are coordinated through our Grants Management Department. Policies are in place to allocate and manage institutional funds that support research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
7P30CA006927-50
Application #
8475332
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
50
Fiscal Year
2013
Total Cost
$130,415
Indirect Cost
Name
Research Institute of Fox Chase Cancer Center
Department
Type
DUNS #
064367329
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Fareed, Muhammad M; Eldib, Ahmed; Weiss, Stephanie E et al. (2018) A treatment planning comparison between a novel rotating gamma system and robotic linear accelerator based intracranial stereotactic radiosurgery/radiotherapy. Phys Med Biol 63:035029
Bleicher, Richard J (2018) Timing and Delays in Breast Cancer Evaluation and Treatment. Ann Surg Oncol 25:2829-2838
Bai, Tian; Chanda, Ashis Kumar; Egleston, Brian L et al. (2018) EHR phenotyping via jointly embedding medical concepts and words into a unified vector space. BMC Med Inform Decis Mak 18:123
Mehrazin, Reza; Dulaimi, Essel; Uzzo, Robert G et al. (2018) The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma. Ther Adv Urol 10:3-10
Tang, Baiqing; Lee, Hyung-Ok; An, Serim S et al. (2018) Specific Targeting of MTAP-Deleted Tumors with a Combination of 2'-Fluoroadenine and 5'-Methylthioadenosine. Cancer Res 78:4386-4395
Fang, Carolyn Y; Tseng, Marilyn (2018) Ethnic density and cancer: A review of the evidence. Cancer 124:1877-1903
Malik, R; Luong, T; Cao, X et al. (2018) Rigidity controls human desmoplastic matrix anisotropy to enable pancreatic cancer cell spread via extracellular signal-regulated kinase 2. Matrix Biol :
Giri, Veda N; Obeid, Elias; Hegarty, Sarah E et al. (2018) Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling. Prostate 78:879-888
Anari, Fern; O'Neill, John; Choi, Woonyoung et al. (2018) Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial. Eur Urol Oncol 1:54-60
Drilon, Alexander; Laetsch, Theodore W; Kummar, Shivaani et al. (2018) Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med 378:731-739

Showing the most recent 10 out of 1280 publications